Tr1X is a private, clinical-stage biotechnology company focused on developing a novel class of regulatory T cell-based products to cure autoimmune and inflammatory diseases.
Tr1X is seeking a Senior Scientist to lead the design, development, and optimization of lipid nanoparticle (LNP) formulation and process development efforts for their in vivo CAR-Treg platform.
Tr1X is a private, clinical-stage biotechnology company focused on developing a novel class of regulatory T cell-based products to cure autoimmune and inflammatory diseases.